EUVIMEDEUVIMED entdecken
Leitlinie

Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

Thomas W Flaig, Philippe E Spiess, Michael Abern, Yi An, Rick Bangs, Jovan Begovic, Jason Brown, Mark K Buyyounouski, Kevin Chan, Paul Chang, Arnold I Chin, Khurshid A Guru und 24 weitere

Journal of the National Comprehensive Cancer Network · 2026-05 · 24 (5) · 186-203

DOI: 10.6004/jnccn.2026.0022 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-05. Verfasst von Thomas W Flaig und 35 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Colorado Cancer Center. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Medical Oncology. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 274 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NCCN Guidelines for Bladder Cancer provide strategies for the diagnosis, treatment, and follow-up of patients with bladder cancer, which is the sixth most common cancer in the United States. Bladder cancer can be divided into 3 categories along a clinical spectrum: (1) non–muscle-invasive bladder cancer; (2) muscle-invasive bladder cancer; and (3) metastatic bladder cancer, with most patients falling into the category of non–muscle-invasive disease. Thus, the selected content featured in this issue specifically covers the clinical presentation and workup of and subsequent management recommendations for non–muscle-invasive bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsMedical OncologyHumansNon-Muscle Invasive Bladder NeoplasmsUnited States

Autor:innen und Institutionen

  • 1University of Colorado Cancer Center.
  • 2Moffitt Cancer Center.
  • 3Duke Cancer Institute.
  • 4Yale Cancer Center/Smilow Cancer Hospital.
  • 5Patient Advocate.
  • 6UT Southwestern Simmons Comprehensive Cancer Center.

Zitieren

APA

Flaig, T. W., Spiess, P. E., Abern, M., An, Y., Bangs, R., Begovic, J., Brown, J., Buyyounouski, M. K., Chan, K., Chang, P., Chin, A. I., Guru, K. A., Herr, H. W., Hoffman-Censits, J., Kaimakliotis, H., Kundu, S., Lele, S. M., Luckenbaugh, A., Maldonado, J., …, & Sliker, B. (2026). Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 24(5), 186-203. https://doi.org/10.6004/jnccn.2026.0022

Vancouver

Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, et al. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. 2026;24(5):186-203. doi:10.6004/jnccn.2026.0022

BibTeX
@article{Flaig2026,
  author = {Flaig, Thomas W and Spiess, Philippe E and Abern, Michael and An, Yi and Bangs, Rick and Begovic, Jovan and Brown, Jason and Buyyounouski, Mark K and Chan, Kevin and Chang, Paul and Chin, Arnold I and Guru, Khurshid A and Herr, Harry W and Hoffman-Censits, Jean and Kaimakliotis, Hristos and Kundu, Shilajit and Lele, Subodh M and Luckenbaugh, Amy and Maldonado, Jonathan and Mei, Lin and Montgomery, Jeffrey S and Parikh, Mamta and Patterson, Anthony and Peyton, Charles and Plimack, Elizabeth R and Preston, Mark A and Richards, Kyle and Seyedin, Steven and Siefker-Radtke, Arlene O and Stewart, Tyler and Sundi, Debasish and Swami, Umang and Tollefson, Matthew and Wright, Jonathan L and Cassara, Carly J and Sliker, Bailee},
  title = {Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {186--203},
  doi = {10.6004/jnccn.2026.0022}
}
Kostenlos starten →